Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-7-31
pubmed:abstractText
We recently demonstrated that dopaminergic (DA) neurons of the rat substantia nigra constitutively expressed CXCR4, receptor for the chemokine stromal cell-derived factor-1 (SDF-1)/CXCL12 (SDF-1). To check the physiological relevance of such anatomical observation, in vitro and in vivo approaches were used. Patch clamp recording of DA neurons in rat substantia nigra slices revealed that SDF-1 (10 nmol/L) induced: (i) a depolarization and increased action potential frequency; and (ii) switched the firing pattern of depolarized DA neurons from a tonic to a burst firing mode. This suggests that SDF-1 could increase DA release from neurons. Consistent with this hypothesis, unilateral intranigral injection of SDF-1 (50 ng) in freely moving rat decreased DA content and increased extracellular concentrations of DA and metabolites in the ipsilateral dorsal striatum, as shown using microdialysis. Furthermore, intranigral SDF-1 injection induced a contralateral circling behavior. These effects of SDF-1 were mediated via CXCR4 as they were abrogated by administration of a selective CXCR4 antagonist. Altogether, these data demonstrate that SDF-1, via CXCR4, activates nigrostriatal DA transmission. They show that the central functions of chemokines are not restricted, as originally thought, to neuroinflammation, but extend to neuromodulatory actions on well-defined neuronal circuits in non-pathological conditions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-3042
pubmed:author
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1175-83
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17509088-Action Potentials, pubmed-meshheading:17509088-Animals, pubmed-meshheading:17509088-Behavior, Animal, pubmed-meshheading:17509088-Brain Chemistry, pubmed-meshheading:17509088-Chemokine CXCL12, pubmed-meshheading:17509088-Chemokines, CXC, pubmed-meshheading:17509088-Corpus Striatum, pubmed-meshheading:17509088-Dopamine, pubmed-meshheading:17509088-Dose-Response Relationship, Drug, pubmed-meshheading:17509088-Functional Laterality, pubmed-meshheading:17509088-Male, pubmed-meshheading:17509088-Microdialysis, pubmed-meshheading:17509088-Motor Activity, pubmed-meshheading:17509088-Rats, pubmed-meshheading:17509088-Rats, Wistar, pubmed-meshheading:17509088-Receptors, CCR4, pubmed-meshheading:17509088-Receptors, Chemokine, pubmed-meshheading:17509088-Substantia Nigra, pubmed-meshheading:17509088-Tyrosine 3-Monooxygenase
pubmed:year
2007
pubmed:articleTitle
The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system.
pubmed:affiliation
Institut National de la Santé et de la Recherche Médicale (INSERM) U 732, Université Pierre et Marie Curie-Paris 6, Hôpital Saint-Antoine, Paris Cedex, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't